Health Perspectives: Musk vs. Kennedy

Elon Musk's endorsement of the weight loss drug Monjaro contrasts sharply with Robert F. Kennedy Jr.'s skepticism regarding medications like Ozempic. While Musk sees medication as a means to improve public health, claiming that expanding access could greatly benefit society, Kennedy argues for an approach focused on lifestyle changes and dietary quality. He points out that other countries, like Denmark, advise against the drugs for obesity, advocating instead for behavioral changes. This ideological divide reflects not just personal beliefs but also differing visions for health policy within a future administration.